Results 71 to 80 of about 1,011 (123)

miRNA gene mutations commonly disrupt the proper functioning of miRNA genes. [PDF]

Sci Adv
Machowska M, Szostak N, Tire A, Wegorek W, Suszynska M, Kajdasz A, Galka-Marciniak P, Philips A, Kozlowski P.   +8 more
europepmc   +1 more source

IsoSeek for unbiased and UMI-informed sequencing of miRNAs from low input samples at single-nucleotide resolution. [PDF]

STAR Protoc, 2023
van Eijndhoven MAJ, Scheepbouwer C, Aparicio-Puerta E, Hackenberg M, Pegtel DM.   +4 more
europepmc   +1 more source

Targetome profile of hsa-miR-93-5p is resistant to isoform formation in prostate adenocarcinoma. [PDF]

PeerJ
Zhiyanov A, Kirillov I, Suvorov R, Maltseva D, Tonevitsky A.   +4 more
europepmc   +1 more source

Plasma isomiRs as Candidate Biomarkers for Amyotrophic Lateral Sclerosis. [PDF]

Neurol Genet
Magee RG, Van Deerlin VM, McMillan CT, Lee EB, Elman LB, Irwin DJ, Mourelatos Z.   +6 more
europepmc   +1 more source

5'‑isomiR is the most abundant sequence of miR‑1246, a candidate biomarker of lung cancer, in serum. [PDF]

Mol Med Rep, 2023
Aiso T, Ueda M.
europepmc   +1 more source

Regulatory QTLs affecting miRNA-mRNA interactions in cancer: mechanisms, methods, and clinical implications. [PDF]

Front Mol Biosci
Kumar V, Shukla R, Chaudhary A, Gautam M.   +3 more
europepmc   +1 more source

Benchmarking of bioinformatics tools for NGS-based microRNA profiling with RT-qPCR method. [PDF]

Funct Integr Genomics, 2023
Pawlina-Tyszko K, Szmatoła T.
europepmc   +1 more source

Higher diversity and abundance of microRNA-455-5p isoforms confer suppressive role in Wilms' tumor. [PDF]

Front Oncol
Chen C, Zhou Z, Yao C, Li X, Wang Y, Zhou X, Ni H.   +6 more
europepmc   +1 more source

Differentially Expressed Conserved Plant Vegetative Phase-Change-Related microRNAs in Mature and Rejuvenated Silver Birch In Vitro Propagated Tissues. [PDF]

Plants (Basel), 2023
Krivmane B, Ruņģe KS, Samsone I, Ruņģis DE.   +3 more
europepmc   +1 more source

RNA cargo profiling of muscle extracellular vesicles identifies candidate biomarkers of disease activity and muscle degeneration in FSHD. [PDF]

J Transl Med
Ragozzino E, Bortolani S, Di Pietro L, Orecchini E, Papait A, Nanni S, Torchia E, Monforte M, Ravera B, Giacò L, Mantini G, Torella A, Nigro V, Sibilia D, Kaur G, Giacalone F, Sabino A, Papacci M, Augello A, Lucchetti D, Sgambato A, Tasca G, Saccone V, Lattanzi W, Parolini O, Ricci E.   +25 more
europepmc   +1 more source